CVS Health's board has engaged advisors for a strategic review amid potential activist pressure and a significantly depressed stock price. The review has been ongoing, but no actions are guaranteed, according to sources. CVS CEO Karen Lynch recently met with Glenview Capital to discuss plans to revive the company’s stock. Its insurance business faces challenges due to rising medical costs. CVS shares rose by more than 2% in after-hours trading following the news.
